Adrenoleukodystrophy: Impaired Oxidation of Very Long Chain Fatty Acids in White Blood Cells, Cultured Skin Fibroblasts, and Amniocytes, Pediatric Research, vol.18, issue.3, pp.286-290, 1984. ,
DOI : 10.1203/00006450-198403000-00016
Method for Measurement of Peroxisomal Very-Long-Chain Fatty Acid ??-Oxidation in Human Skin Fibroblasts Using Stable-Isotope-Labeled Tetracosanoic Acid, Clinical Chemistry, vol.50, issue.10, pp.1824-1826, 2004. ,
DOI : 10.1373/clinchem.2004.038539
Adrenoleukodystrophy: Increased plasma content of saturated very long chain fatty acids, Neurology, vol.31, issue.10, pp.1241-1249, 1981. ,
DOI : 10.1212/WNL.31.10.1241
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters, Nature, vol.361, issue.6414, pp.726-730, 1993. ,
DOI : 10.1038/361726a0
The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters, The FASEB Journal, vol.22, issue.12, pp.4201-4208, 2008. ,
DOI : 10.1096/fj.08-110866
The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy, EMBO Molecular Medicine, vol.27, issue.3, pp.90-97, 2010. ,
DOI : 10.1002/emmm.201000061
Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes, American Journal of Medical Genetics, vol.44, issue.5, pp.415-419, 1998. ,
DOI : 10.1002/(SICI)1096-8628(19980413)76:5<415::AID-AJMG9>3.0.CO;2-L
ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations, Human Mutation, vol.57, issue.7, pp.499-515, 2001. ,
DOI : 10.1002/humu.1227
Newborn screening for X-linked adrenoleukodystrophy (X-ALD): Validation of a combined liquid chromatography???tandem mass spectrometric (LC???MS/MS) method, Molecular Genetics and Metabolism, vol.97, issue.3, pp.212-220, 2009. ,
DOI : 10.1016/j.ymgme.2009.03.010
Über einen interessanten fall von gliomatöser Infiltration bei der Großhirnhemisphäre, Arch Psychiatr Nervenkr, vol.1899, issue.31, pp.809-819 ,
DOI : 10.1007/bf02047161
Zur diffusen Hirn-R??ckenmarksklerose im Kindesalter, Deutsche Zeitschrift f??r Nervenheilkunde, vol.19, issue.Nr. 49, pp.436-463, 1910. ,
DOI : 10.1007/BF01629013
Zur Kenntnis der sogenannten diffusen Sklerose. (??ber Encephalitis periaxialis diffusa.), Zeitschrift f??r die gesamte Neurologie und Psychiatrie, vol.36, issue.1, pp.1-60, 1912. ,
DOI : 10.1007/BF02901445
Zur Frage der Encephalitis periaxialis diffusa (sogenannte diffuse Sklerose), Zeitschrift f??r die gesamte Neurologie und Psychiatrie, vol.26, issue.1, pp.359-376, 1913. ,
DOI : 10.1007/BF02895263
Die Encephalitis periaxialis diffusa, Archiv f??r Psychiatrie und Nervenkrankheiten, vol.52, issue.1, pp.327-356, 1924. ,
DOI : 10.1007/BF01813381
DIFFUSE CEREBRAL SCLEROSIS WITH ENDOCRINE ABNORMALITIES IN YOUNG MALES, Brain, vol.85, issue.3, pp.553-568, 1962. ,
DOI : 10.1093/brain/85.3.553
Bronzekrankheit und sklerosierende Encephalomyelitis, Archiv f??r Psychiatrie und Nervenkrankheiten, vol.7, issue.69, pp.217-244, 1923. ,
DOI : 10.1007/BF01835678
Melanodermic type leukodystrophy (adreno-leukodystrophy)In Handbook of Clinical Neurology, pp.128-133 ,
Adrenocortical Atrophy and Diffuse Cerebral Sclerosis, Archives of Disease in Childhood, vol.46, issue.247, pp.273-284, 1971. ,
DOI : 10.1136/adc.46.247.273
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1647695/pdf
Schilder's Disease, Archives of Neurology, vol.27, issue.5, pp.458-460, 1972. ,
DOI : 10.1001/archneur.1972.00490170090014
FATTY ACID ABNORMALITY IN ADRENOLEUKODYSTROPHY, Journal of Neurochemistry, vol.49, issue.4, pp.851-860, 1976. ,
DOI : 10.1111/j.1471-4159.1976.tb04461.x-i1
Die Erkrankungen der Nebennieren, p.133, 2011. ,
Familial Addison's disease with spastic paraplegia, J Clin Endocrinol Metab, vol.15, pp.739-744, 1955. ,
Addison's Disease in Association with Spastic Paraplegia, BMJ, vol.1, issue.5170, p.402, 1960. ,
DOI : 10.1136/bmj.1.5170.402
Spastic paraplegia associated with addison's disease: Adult variant of adreno-leukodystrophy, Journal of Neurology, vol.42, issue.3, pp.237-250, 1976. ,
DOI : 10.1007/BF00312873
Adrenomyeloneuropathy: A probable variant of adrenoleukodystrophy I. Clinical and endocrinologic aspects, Neurology, vol.27, issue.12, pp.1107-1113, 1977. ,
DOI : 10.1212/WNL.27.12.1107
X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients, J Clin Endocrinol Metab, vol.81, pp.470-474, 1996. ,
Presentation of Primary Adrenal Insufficiency in Childhood, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.6, pp.925-928, 2011. ,
DOI : 10.1210/jc.2011-0015
Absence of Circulating Adrenal Autoantibodies in Adult-Onset X-Linked Adrenoleukodystrophy, Hormone and Metabolic Research, vol.28, issue.07, pp.319-322, 1996. ,
DOI : 10.1055/s-2007-979803
X-linked adrenoleukodystrophy.I nThe Metabolic and Molecular Bases of Inherited Disease, pp.3257-3301, 2001. ,
X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy, Journal of Neurology, Neurosurgery & Psychiatry, vol.63, issue.1, pp.4-14, 1997. ,
DOI : 10.1136/jnnp.63.1.4
The Inflammatory Myelinopathy of Adreno-Leukodystrophy, Journal of Neuropathology and Experimental Neurology, vol.51, issue.6, pp.630-643, 1992. ,
DOI : 10.1097/00005072-199211000-00007
X-linked adrenoleukodystrophy.I nMagnetic Resonance of Myelination and Myelin Disorders, pp.176-190, 2005. ,
Asymmetric Cerebral Lesion Pattern in X-linked Adrenoleukodystrophy, Journal of the Chinese Medical Association, vol.69, issue.8, pp.383-386, 2006. ,
DOI : 10.1016/S1726-4901(09)70277-1
Adrenoleukodystrophy: a scoring method for brain MR observations, AJNR Am J Neuroradiol, vol.15, pp.1761-1766, 1994. ,
Late-Onset Adrenoleukodystrophy Associated With Long-Standing Psychiatric Symptoms, The Journal of Clinical Psychiatry, vol.60, issue.7, pp.460-468, 1999. ,
DOI : 10.4088/JCP.v60n0708
X-linked adrenoleukodystrophy, Nature Clinical Practice Neurology, vol.89, issue.3, pp.140-151, 2007. ,
DOI : 10.1038/ncpneuro0421
Peripheral nerve abnormalities in adrenomyeloneuropathy: A clinical and electrodiagnostic study, Neurology, vol.46, issue.1, pp.112-118, 1996. ,
DOI : 10.1212/WNL.46.1.112
X-linked adrenomyeloneuropathy due to a novel missense mutation in the ABCD1 start codon presenting as demyelinating neuropathy, Journal of the Peripheral Nervous System, vol.18, issue.Suppl 1, pp.353-355, 2011. ,
DOI : 10.1111/j.1529-8027.2011.00367.x
Polyneuropathies in teenagers: A clinicopathological study of 45 cases, Neuromuscular Disorders, vol.16, issue.5, pp.304-307, 2006. ,
DOI : 10.1016/j.nmd.2006.03.001
Adrenomyeloneuropathy, Journal of Neuropathology & Experimental Neurology, vol.59, issue.2, pp.89-102, 2000. ,
DOI : 10.1093/jnen/59.2.89
Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy, Annals of Neurology, vol.64, issue.5, pp.758-766, 2005. ,
DOI : 10.1002/ana.20643
Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy, Neurology, vol.64, issue.10, pp.1739-1745, 2005. ,
DOI : 10.1212/01.WNL.0000164458.02141.06
Quantitative magnetization transfer characteristics of the human cervical spinal cord in vivo: Application to Adrenomyeloneuropathy, Magnetic Resonance in Medicine, vol.254, issue.1, pp.22-27, 2009. ,
DOI : 10.1002/mrm.21827
Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy, Annals of Neurology, vol.78, issue.2 ,
DOI : 10.1002/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R
Clinical Aspects of Adrenoleukodystrophy and Adrenomyeloneuropathy, Developmental Neuroscience, vol.13, issue.4-5, pp.254-261, 1991. ,
DOI : 10.1159/000112170
Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study, International Journal of Andrology, vol.20, issue.5, pp.315-321, 1997. ,
DOI : 10.1046/j.1365-2605.1997.00066.x
Adrenoleukodystrophy: Clinical and biochemical manifestations in carriers, Neurology, vol.34, issue.6, pp.798-801, 1984. ,
DOI : 10.1212/WNL.34.6.798
Assessment of Adrenal Function in Women Heterozygous for Adrenoleukodystrophy, Journal of Clinical Endocrinology & Metabolism, vol.82, issue.3, pp.856-860, 1997. ,
DOI : 10.1210/jc.82.3.856
X-chromosome inactivation in symptomatic heterozygotes of X-linked adrenoleukodystrophy, Ann Neurol, vol.42, p.498, 1997. ,
Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation, Annals of Neurology, vol.248, issue.5, pp.683-688, 2002. ,
DOI : 10.1002/ana.10376
Preferential expression of mutant ABCD1 allele is common in adrenoleukodystrophy female carriers but unrelated to clinical symptoms, Orphanet Journal of Rare Diseases, vol.7, issue.1, p.10, 2012. ,
DOI : 10.1056/NEJM198301273080401
X-Linked Adrenoleukodystrophy (ALD): A Novel Mutation of the ALD Gene in 6 Members of a Family Presenting with 5 Different Phenotypes, Biochemical and Biophysical Research Communications, vol.205, issue.3, pp.1638-1643, 1994. ,
DOI : 10.1006/bbrc.1994.2855
Identification of a Two Base Pair Deletion in Five Unrelated Families with Adrenoleukodystrophy: A Possible Hot Spot for Mutations, Biochemical and Biophysical Research Communications, vol.202, issue.2, pp.647-653, 1994. ,
DOI : 10.1006/bbrc.1994.1979
Predictions of a 2-locus model for disease heterogeneity: Application to adrenoleukodystrophy, American Journal of Medical Genetics, vol.305, issue.5, pp.576-582, 1992. ,
DOI : 10.1002/ajmg.1320440509
A genetic basis for the multiple phenotypes of X-linked adrenoleukodystrophy, Am J Hum Genet, vol.49, p.165, 1991. ,
Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance, British Journal of Pharmacology, vol.32, issue.7, pp.1753-1766, 2011. ,
DOI : 10.1111/j.1476-5381.2011.01435.x
Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy, Molecular Genetics and Metabolism, vol.84, issue.2, pp.144-151, 2005. ,
DOI : 10.1016/j.ymgme.2004.09.015
Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy., Journal of Clinical Investigation, vol.96, issue.3, pp.1455-1463, 1995. ,
DOI : 10.1172/JCI118182
Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy., Journal of Clinical Investigation, vol.72, issue.1, pp.245-248, 1983. ,
DOI : 10.1172/JCI110963
Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro., Journal of Clinical Investigation, vol.81, issue.1, pp.185-188, 1988. ,
DOI : 10.1172/JCI113292
Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture, Human Molecular Genetics, vol.17, issue.12, pp.1750-1761, 2008. ,
DOI : 10.1093/hmg/ddn066
Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy, Human Molecular Genetics, vol.17, issue.12, pp.1762-1773, 2008. ,
DOI : 10.1093/hmg/ddn085
Adreno-leukodystrophy: Oxidative Stress of Mice and Men, Journal of Neuropathology and Experimental Neurology, vol.64, issue.12, pp.1067-1079, 2005. ,
DOI : 10.1097/01.jnen.0000190064.28559.a4
Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?, Annals of Neurology, vol.147, issue.6, pp.729-742, 2008. ,
DOI : 10.1002/ana.21391
Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy, Human Molecular Genetics, vol.11, issue.5, pp.499-505, 2002. ,
DOI : 10.1093/hmg/11.5.499
Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy, Human Molecular Genetics, vol.21, issue.5, pp.1062-1077, 2012. ,
DOI : 10.1093/hmg/ddr536
X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism, Molecular Genetics and Metabolism, vol.104, issue.1-2, pp.160-166, 2011. ,
DOI : 10.1016/j.ymgme.2011.05.016
Etiological Diagnosis of Primary Adrenal Insufficiency Using an Original Flowchart of Immune and Biochemical Markers, Journal of Clinical Endocrinology & Metabolism, vol.83, issue.9, pp.3163-3168, 1998. ,
DOI : 10.1210/jc.83.9.3163
Adrenomyeloneuropathy in patients with `Addison's disease': genetic case analysis, Journal of the Royal Society of Medicine, vol.99, issue.5, pp.245-249, 2006. ,
DOI : 10.1258/jrsm.99.5.245
Myelopathy but normal MRI: where next?, Practical Neurology, vol.8, issue.2, pp.90-102, 2008. ,
DOI : 10.1136/jnnp.2008.144121
Increased very long chain fatty acids in patients on a ketogenic diet: A cause of diagnostic confusion, The Journal of Pediatrics, vol.122, issue.5, pp.724-726, 1993. ,
DOI : 10.1016/S0022-3476(06)80013-2
Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene, Orphanet Journal of Rare Diseases, vol.6, issue.1, p.8, 2011. ,
DOI : 10.1186/1750-1172-6-8
URL : https://hal.archives-ouvertes.fr/inserm-00580953
Mutations in PEX10 are a cause of autosomal recessive ataxia, Annals of Neurology, vol.68, pp.259-263, 2010. ,
DOI : 10.1002/ana.22035
Peroxisomes, lipid metabolism and lipotoxicity, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1801, issue.3, pp.272-280, 2010. ,
DOI : 10.1016/j.bbalip.2010.01.001
Biochemistry of Mammalian Peroxisomes Revisited, Annual Review of Biochemistry, vol.75, issue.1, pp.295-332, 2006. ,
DOI : 10.1146/annurev.biochem.74.082803.133329
Invited Article: An MRI-based approach to the diagnosis of white matter disorders, Neurology, vol.72, issue.8, pp.750-759, 2009. ,
DOI : 10.1212/01.wnl.0000343049.00540.c8
Late onset white matter disease in peroxisome biogenesis disorder, Neurology, vol.57, issue.11, pp.1949-1955, 2001. ,
DOI : 10.1212/WNL.57.11.1949
Rapid detection of common autosomal aneuploidies by quantitative fluorescent PCR on uncultured amniocytes, European Journal of Human Genetics, vol.10, issue.8, pp.462-466, 2002. ,
DOI : 10.1038/sj.ejhg.5200833
Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy, The Lancet, vol.356, issue.9231, pp.713-718, 2000. ,
DOI : 10.1016/S0140-6736(00)02629-5
Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report, Blood, vol.118, issue.7, pp.1971-1978, 2011. ,
DOI : 10.1182/blood-2011-01-329235
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy, Science, vol.326, issue.5954, pp.818-823, 2009. ,
DOI : 10.1126/science.1171242
A Two-Year Trial of Oleic and Erucic Acids (???Lorenzo's Oil???) as Treatment for Adrenomyeloneuropathy, New England Journal of Medicine, vol.329, issue.11, pp.745-752, 1993. ,
DOI : 10.1056/NEJM199309093291101
Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil", Journal of Neurology, Neurosurgery & Psychiatry, vol.67, issue.3, pp.290-299, 1999. ,
DOI : 10.1136/jnnp.67.3.290
Follow-up of 89 Asymptomatic Patients With Adrenoleukodystrophy Treated With Lorenzo???s Oil, Archives of Neurology, vol.62, issue.7, pp.1073-1080, 2005. ,
DOI : 10.1001/archneur.62.7.1073
Lovastatin for X-Linked Adrenoleukodystrophy, New England Journal of Medicine, vol.339, issue.10, pp.702-703, 1998. ,
DOI : 10.1056/NEJM199809033391012
Lovastatin in X-Linked Adrenoleukodystrophy, New England Journal of Medicine, vol.362, issue.3, pp.276-277, 2010. ,
DOI : 10.1056/NEJMc0907735
Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy, Annals of Neurology, vol.256, issue.suppl 1, pp.84-92, 2011. ,
DOI : 10.1002/ana.22363